跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 755 条关于
“REVISIT”
全部
755
临床试验
665
药物
1
机构
0
资讯
89
去年
Recent FDA Approvals and Clinical Trial Updates in Oncology Highlighted on OncLive On Air
2年前
EU Approves Pfizer's Emblaveo: First-in-Class Antibiotic for Multi-Drug Resistant Infections
去年
Donanemab Approved by MHRA but Rejected by NICE for NHS Use Due to Cost Concerns
2年前
FDA Meeting Highlights Urgent Need for Innovative PTSD Therapies, Including MDMA-Assisted Therapy
8个月前
Large UK Trial Finds FDA-Cleared ADHD Device Ineffective Despite Safety Profile
上个月
Hong Kong Trial Tests Controversial Surgery for Alzheimer's Patients After China Bans Unregulated Use
去年
MeMed BV Test Reduces Antibiotic Overuse in Lower Respiratory Infections
去年
FDA Approves Novel Antibiotic Combination Emblaveo for Complex Abdominal Infections
去年
Race Oncology Secures Breakthrough Patent Protection for Purified Bisantrene Cancer Drug
去年
UroGen's UGN-102 Nears FDA Approval with Impressive Phase 3 Results for Bladder Cancer
第 1 页,共 9 页
上一页
下一页